511 related articles for article (PubMed ID: 35935942)
21. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
Haradhvala NJ; Polak P; Stojanov P; Covington KR; Shinbrot E; Hess JM; Rheinbay E; Kim J; Maruvka YE; Braunstein LZ; Kamburov A; Hanawalt PC; Wheeler DA; Koren A; Lawrence MS; Getz G
Cell; 2016 Jan; 164(3):538-49. PubMed ID: 26806129
[TBL] [Abstract][Full Text] [Related]
22. Role of Rad51 and DNA repair in cancer: A molecular perspective.
Laurini E; Marson D; Fermeglia A; Aulic S; Fermeglia M; Pricl S
Pharmacol Ther; 2020 Apr; 208():107492. PubMed ID: 32001312
[TBL] [Abstract][Full Text] [Related]
23. Princess takamatsu symposium on DNA repair and human cancers.
Loeb LA; Nishimura S
Cancer Res; 2010 Jun; 70(11):4269-73. PubMed ID: 20460534
[TBL] [Abstract][Full Text] [Related]
24. Targeting DNA Repair.
Curigliano G
Handb Exp Pharmacol; 2018; 249():161-180. PubMed ID: 30341723
[TBL] [Abstract][Full Text] [Related]
25. DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.
Rabenau K; Hofstatter E
Clin Ther; 2016 Jul; 38(7):1577-88. PubMed ID: 27368114
[TBL] [Abstract][Full Text] [Related]
26. Multiple roles of BRIT1/MCPH1 in DNA damage response, DNA repair, and cancer suppression.
Lin SY; Liang Y; Li K
Yonsei Med J; 2010 May; 51(3):295-301. PubMed ID: 20376879
[TBL] [Abstract][Full Text] [Related]
27. DNA damage and innate immunity: links and trade-offs.
Chatzinikolaou G; Karakasilioti I; Garinis GA
Trends Immunol; 2014 Sep; 35(9):429-35. PubMed ID: 25023467
[TBL] [Abstract][Full Text] [Related]
28. DNA damage and repair measured by comet assay in cancer patients.
Vodicka P; Vodenkova S; Opattova A; Vodickova L
Mutat Res Genet Toxicol Environ Mutagen; 2019 Jul; 843():95-110. PubMed ID: 31421745
[TBL] [Abstract][Full Text] [Related]
29. Hypermutation in human cancer genomes: footprints and mechanisms.
Roberts SA; Gordenin DA
Nat Rev Cancer; 2014 Dec; 14(12):786-800. PubMed ID: 25568919
[TBL] [Abstract][Full Text] [Related]
30. Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
Telli ML; Stover DG; Loi S; Aparicio S; Carey LA; Domchek SM; Newman L; Sledge GW; Winer EP
Breast Cancer Res Treat; 2018 Aug; 171(1):21-31. PubMed ID: 29736741
[TBL] [Abstract][Full Text] [Related]
31. The accumulation of DNA repair defects is the molecular origin of carcinogenesis.
Cha HJ; Yim H
Tumour Biol; 2013 Dec; 34(6):3293-302. PubMed ID: 23907577
[TBL] [Abstract][Full Text] [Related]
32. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans.
Mohrenweiser HW; Xi T; Vázquez-Matías J; Jones IM
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1054-64. PubMed ID: 12376507
[TBL] [Abstract][Full Text] [Related]
33. Topoisomerase-mediated chromosomal break repair: an emerging player in many games.
Ashour ME; Atteya R; El-Khamisy SF
Nat Rev Cancer; 2015 Mar; 15(3):137-51. PubMed ID: 25693836
[TBL] [Abstract][Full Text] [Related]
34. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.
Ray Chaudhuri A; Nussenzweig A
Nat Rev Mol Cell Biol; 2017 Oct; 18(10):610-621. PubMed ID: 28676700
[TBL] [Abstract][Full Text] [Related]
35. DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy.
de Almeida LC; Calil FA; Machado-Neto JA; Costa-Lotufo LV
Cancer Genet; 2021 Apr; 252-253():6-24. PubMed ID: 33340831
[TBL] [Abstract][Full Text] [Related]
36. DNA repair and damage pathways in breast cancer development and therapy.
Majidinia M; Yousefi B
DNA Repair (Amst); 2017 Jun; 54():22-29. PubMed ID: 28437752
[TBL] [Abstract][Full Text] [Related]
37. Role of DNA Repair Deficiency in Cancer Development.
Alhegaili AS
Pak J Biol Sci; 2023 Jan; 26(1):15-22. PubMed ID: 37129201
[TBL] [Abstract][Full Text] [Related]
38. LncRNAs in DNA damage response and repair in cancer cells.
Su M; Wang H; Wang W; Wang Y; Ouyang L; Pan C; Xia L; Cao D; Liao Q
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):433-439. PubMed ID: 29554194
[TBL] [Abstract][Full Text] [Related]
39. The natural somatic mutation frequency and human carcinogenesis.
Simpson AJ
Adv Cancer Res; 1997; 71():209-40. PubMed ID: 9111867
[TBL] [Abstract][Full Text] [Related]
40. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
